# Intention-to-treat outcomes of patients with hepatocellular carcinoma receiving immunotherapy before liver transplant: The multicenter VITALITY study

*PRI Rank #14 · Topics and Trends in Most Cited Hepatocellular Carcinoma Treatment and Prognosis Papers, Class of 2026*

*Canonical URL: https://pri.pepkio.com/top-papers/hepatocellular-carcinoma-treatment-and-prognosis/2026/rank-14*

| Field | Value |
| --- | --- |
| Rank | #14 |
| 18m citations | 61 |
| Journal | Journal of Hepatology |
| Year | 2024 |
| DOI | 10.1016/j.jhep.2024.09.003 |
| Corresponding authors | Parissa Tabrizian |
| Institution | Icahn School of Medicine at Mount Sinai, United States |

**Ranking page:** [Topics and Trends in Most Cited Hepatocellular Carcinoma Treatment and Prognosis Papers, Class of 2026](https://pri.pepkio.com/top-papers/hepatocellular-carcinoma-treatment-and-prognosis/2026)

**Paper link:** [10.1016/j.jhep.2024.09.003](https://doi.org/10.1016/j.jhep.2024.09.003)

## Topics

Hepatocellular carcinoma · liver transplantation · Immunotherapy · Intention-to-treat analysis · Multicenter study · VITALITY study · bridging therapy · Downstaging · Immune checkpoint inhibitor therapy · waitlist outcomes · Transplant outcomes · Allograft rejection · PD-1/PD-L1 inhibitor · tumor response · Milan criteria · transplant eligibility · Recurrence-free survival · Overall survival · Neoadjuvant immunotherapy · graft-versus-host disease · immunosuppression · alpha-fetoprotein · Downstaging · dropout rate · waitlist mortality

## Cite this ranking

```
Pepkio Research Index (PRI). Topics and Trends in Most Cited Hepatocellular Carcinoma Treatment and Prognosis Papers, Class of 2026. https://pri.pepkio.com/top-papers/hepatocellular-carcinoma-treatment-and-prognosis/2026. Accessed 2026-07-14.

Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459
```